X hits on this document

PDF document

*Denotes a generic available in at least one dosage form or strength - page 20 / 26

83 views

0 shares

0 downloads

0 comments

20 / 26

This PDL reference tool is to aid a prescribing physician with generic availability and preferred product status. A “substitution allowed” physician signature on a prescription should not require a PA to be obtained if a generic agent is available.

none

mupirocin mupirocin clindamycin phosphate

metronidazole neomycin and polymyxin B metronidazole vaginal bacitracin and polymyxin B gentamicin neomycin, bacitracin and polymyxin B

Altabax Bactroban* Centany* Cleocin* Clindesse Cortisporin MetroGel Vaginal* Neosporin G.U. Irrigant* Vandazole*

Zovirax

none

Denavir Veregen

none

ketoconazole

ciclopirox clotrimazole and betamethasone

Bensal HP Ertaczo Exelderm Gynazole-1 Kuric* Lamisil Loprox* Lotrisone*

clotrimazole

ciclopirox terconazole terconazole

terconazole econazole miconazole nystatin nystatin and triamcinolone sodium thiosulfate and salicylic acid terbinafine tolnaftate

Mentax Mycelex* Naftin Oxistat Penlac* Terazol 3* Terazol 7* Vusion Xolegel Xolegel Duo Zazole*

Eurax

permethrin permethrin

malathion piperonyl butoxide and pyrethrins

Acticin* Elimite* lindane (generic) Ovide *

*Denotes a generic available in at least one dosage form or strength **Will be reviewed at a future time when eligible

Effective 4/1/2010

20

Document info
Document views83
Page views84
Page last viewedThu Dec 08 23:41:56 UTC 2016
Pages26
Paragraphs745
Words4095

Comments